Comparison of Biosimilar Filgrastim with Innovator Fligrastim for Peripheral Blood Stem Cells Mobilization, Collection of CD34+ Stem Cells, and Engraftment in Patients Undergoing Autologous and Allogeneic Stem Cell Transplantation: A Single-Center Experience

CONCLUSIONS Our study showed that biosimilar G-CSF (Zarzio®) has comparable efficacy to the original G-CSF (Neupogen®) when used for mobilization in both autologous and allogenic stem cell transplantation and was associated with significant cost saving.PMID:36864713 | DOI:10.12659/AOT.938585

Source: Annals of Transplantation - March 3, 2023 Category: Transplant Surgery Authors: Maha M Islami Mansoor Ahmed Khan Mohammed A Aseeri Majed A Alshamrani Abdelmajid Alnatsheh Sameer Alamoudi Ahmed A Alzahrani Source Type: research